Who are Skye Bioscience, Inc.'s main suppliers?

Skye Bioscience, Inc. (SKYE) key suppliers include: HALOZYME-INC, LOHMAN-ASSOCIATES-INC. View the full supplier network at chainsifter.com/chain/SKYE.

Who are Skye Bioscience, Inc.'s major customers?

Skye Bioscience, Inc. (SKYE) key customers include: iBio, Inc., SciSparc Ltd.. View the full customer network at chainsifter.com/chain/SKYE.

What sector is Skye Bioscience, Inc. in?

Skye Bioscience, Inc. (SKYE) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

SKYE Supply Chain: Skye Bioscience, Inc. Suppliers & Customers

2Suppliers

2Customers

3Debt Items

20Related Chains

Skye Bioscience, Inc. Suppliers

Ticker	Name	Confidence	Evidence
HALOZYME-INC	HALOZYME-INC	92%	Halozyme will also be the Company's exclusive supplier of clinical and commercial supplies of the API for Halozyme's rHuPH20 bulk drug product.
LOHMAN-ASSOCIATES-INC	LOHMAN-ASSOCIATES-INC	92%	In connection with the appointment of Mr. Sharp, on March 31, 2026, the Company entered into a Master Services Agreement (the “Master Services Agreement”)with L&A, pursuant to which L&A agreed to pro…

Skye Bioscience, Inc. Customers

Ticker	Name	Confidence	Evidence
IBIO	iBio, Inc.	72%	Reciprocal relationship from IBIO graph: Biohaven, Ltd., Structure Therapeutics, Inc., Viking Therapeutics, Inc., Veru Inc., Zealand Pharma A/S, Metsera, Inc., Terns Pharmaceuticals, Inc., Skye Biosc…
SPRC	SciSparc Ltd.	72%	Reciprocal relationship from SPRC graph: Reciprocal relationship from SKYE graph: Reciprocal relationship from SPRC graph: Reciprocal relationship from SKYE graph: Reciprocal relationship from SPRC g…

Skye Bioscience, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
SKYE-DEBT	Debt stack $311,318	90%	Market cache reports total debt of $311,318.
SKYE-DEBT-12562	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.
SKYE-DEBT-12561	Warrants outstanding: 100000	90%	xbrl warrant detail from xbrl 2024-12-31.

Skye Bioscience, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Skye Bioscience, Inc..

Skye Bioscience, Inc. Ownership

Holder	Name	Confidence	Evidence
SKYE-OWNER-5AM-VENTURE-MANAGEMENT-LLC	5AM Venture Management, LLC	90%	13F overlay lists 5AM Venture Management, LLC as top holder; 41 tracked holders.

Skye Bioscience, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
IBIO	iBio, Inc.	100.00	1	['customer']
SPRC	SciSparc Ltd.	100.00	1	['customer']
ORANY	ORANGE	50.00	2
VKTX	Viking Therapeutics, Inc.	50.00	2
ARWR	Arrowhead Pharmaceuticals, Inc.	50.00	2
BMY	Bristol-Myers Squibb Company	50.00	2
BMYMP	Bristol-Myers Squibb Co	50.00	2
GILD	Gilead Sciences, Inc.	50.00	2
HRMY	Harmony Biosciences Holdings, Inc.	50.00	2
TWST	Twist Bioscience Corporation	50.00	2
MTEK	Maris-Tech Ltd.	50.00	2
NITO	Nexentis Technologies Inc.	50.00	2
RVSN	Rail Vision Ltd.	50.00	2
MRK	Merck & Co., Inc.	50.00	2
TERN	Terns Pharmaceuticals, Inc.	50.00	2
PRZO	ParaZero Technologies Ltd.	50.00	2
NEXRW	Nexera Technologies Ltd	50.00	2
JNJ	Johnson & Johnson	50.00	2
KROS	Keros Therapeutics, Inc.	50.00	2
LLY	Eli Lilly and Company	50.00	2

Skye Bioscience, Inc. Supply Chain